|
1) Ronaghi M, Erceg S, Moreno-Manzano V, et al. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells？ Stem Cells. 2010; 28: 93-9
|
|
|
|
2) Hawryluk GW, Rowland J, Kwon BK, et al. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus. 2008; 25: E14
|
|
|
|
|
|
3) Boulenguez P, Vinay L. Strategies to restore motor functions after spinal cord injury. Curr Opin Neurobiol. 2009; 19: 587-600
|
|
|
|
|
4) Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A Systematic Review of Cellular Transplantation Therapies for Spinal Cord Injury. J Neurotrauma. 2010 Apr 20. [Epub ahead of print]
|
|
|
|
|
|
5) Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A. 2010; 107: 12704-9
|
|
|
|
|
|
6) Lima C, Pratas-Vital J, Escada P, et al. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med. 2006; 29: 191-203
|
|
|
|
|
|
7) Lima C, Escada P, Pratas-Vital J, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair. 2009; 24: 10-22
|
|
|
|
|
|
8) James WF. Intrinsic Control of Regeneration and the Loss of Regenerative Ability in Development. In: Nicholas AI, Marion M, (ed). Axonal Regeneration in the Central Nervous System. New York: Marcel Dekker, Inc; 2001. p.161-84
|
|
|
|
|
|
9) Rowland JW, Hawryluk GW, Kwon B, et al. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus. 2008; 25: 1-17
|
|
|
|
|
|
10) Fleming JC, Norenberg MD, Ramsay DA, et al. The cellular inflammatory response in human spinal cords after injury. Brain. 2006; 129: 3249-69
|
|
|
|
|
|
11) Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg. 2000; 93 (1 Suppl): 1-7
|
|
|
|
|
|
12) Pereira JE, Costa LM, Cabrita AM, et al. Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats. Exp Neurol. 2009; 220: 71-81
|
|
|
|
|
|
13) Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008; 209: 378-88
|
|
|
|
|
|
14) Pineau I, Lacroix S. Endogenous signals initiating inflammation in the injured nervous system. Glia. 2009; 57: 351-61
|
|
|
|
|
|
15) Ankeny DP, Popovich PG. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience. 2009; 158: 1112-21
|
|
|
|
|
|
16) Mukaino M, Nakamura M, Yamada O, et al. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol. 2010; 224: 403-14
|
|
|
|
|
|
17) Genovese T, Esposito E, Mazzon E, et al. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem. 2009; 108: 1360-72
|
|
|
|
|
|
18) Mackay-Sim A, Feron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain. 2008; 131: 2376-86
|
|
|
|
|
|
19) Saberi H, Moshayedi P, Aghayan HR, et al. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett. 2008; 443: 46-50
|
|
|
|
|
|
20) Nistor GI, Totoiu MO, Haque N, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005; 49: 385-96
|
|
|
|
|
|
21) Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A. 2010; 107: 12704-9
|
|
|
|
|
|
22) Nakano N, Nakai Y, Seo TB, et al. Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett. 2010; 483: 57-61
|
|
|
|
|
|
23) Saito F, Nakatani T, Iwase M, et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma. 2008; 64: 53-9
|
|
|
|
|
|
24) Farbman AI. Developmental biology of olfactory sensory neurons. Semin Cell Biol. 1994; 5: 3-10
|
|
|
|
|
|
25) Lindsay SL, Riddell JS, Barnett SC. Olfactory mucosa for transplant-mediated repair: a complex tissue for a complex injury？ Glia. 2010; 58: 125-34
|
|
|
|
|
|
26) Li Y, Field PM, Raisman G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science. 1997; 277: 2000-2
|
|
|
|
|
|
27) Ramon-Cueto A, Plant GW, Avila J, et al. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci. 1998; 18: 3803-15
|
|
|
|
|
|
28) Kafitz KW, Greer CA. Olfactory ensheathing cells promote neurite extension from embryonic olfactory receptor cells in vitro. Glia. 1999; 25: 99-110
|
|
|
|
|
|
29) Lu J, Feron F, Mackay-Sim A, et al. Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain. 2002; 125 (Pt1): 14-21
|
|
|
|
|
|
30) Imaizumi T, Lankford KL, Waxman SG, et al. Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci. 1998; 18: 6176-85
|
|
|
|
|
|
31) Leaver SG, Harvey AR, Plant GW. Adult olfactory ensheathing glia promote the long-distance growth of adult retinal ganglion cell neurites in vitro. Glia. 2006; 53: 467-76
|
|
|
|
|
|
32) van den Pol AN, Santarelli JG. Olfactory ensheathing cells: time lapse imaging of cellular interactions, axonal support, rapid morphologic shifts, and mitosis. J Comp Neurol. 2003; 458: 175-94
|
|
|
|
|
|
33) Tome M, Riddell JS, Barnett SC. Identification of non-epithelial multipotent cells in the embryonic olfactory mucosa. Stem Cells. 2009; 27: 2196-208
|
|
|
|
|
|
34) Roisen FJ, Klueber KM, Lu CL, et al. Adult human olfactory stem cells. Brain Res. 2001; 890: 11-22
|
|
|
|
|
|
35) Murrell W, Feron F, Wetzig A, et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn. 2005; 233: 496-515
|
|
|
|
|
|
36) Xiao M, Kleuber KM, Chenghang L, et al. Human adult olfactory neural progenitors rescue axotomized rodent rubrospinal neurons and promote functional recovery. Exp Neurol. 2005; 194: 12-30
|
|
|
|
|
|
37) Richter MW, Roskams AJ. Olfactory ensheathing cell transplantation following spinal cord injury: Hype or hope？ Exp Neurol. 2008; 209: 353-67
|
|
|
|
|
|
38) Aoki M, Kishima H, Yoshimura K, et al. Limited functional recovery in rats with complete spinal cord injury after transplantation of whole-layer olfactory mucosa: laboratory investigation. J Neurosurg Spine. 2010; 12: 122-30
|
|
|
|
|
|
39) The 26th Annual National Neurotrauma Society Symposium, July, 2008 (Orlando)
|
|
|
|
|